
American Express Global Business Travel (Amex GBT) has reached a milestone in its proposed acquisition of CWT, as the UK’s Competition and Markets Authority (CMA) has provisionally determined that the transaction does not pose competition concerns. According to a statement from Amex GBT, the CMA’s provisional conclusion marks a key step toward finalizing the deal. However, the regulatory body’s final decision is expected by March 9, 2025.
The proposed acquisition, first announced on March 25, 2024, remains subject to customary closing conditions, including regulatory approvals. While the CMA’s findings suggest a smoother path in the UK, Amex GBT continues to face legal challenges in the United States. Per a statement from the company, the Antitrust Division of the U.S. Department of Justice (DOJ) filed a lawsuit in January 2025, seeking an injunction to block the deal on antitrust grounds.
Eric J. Bock, Amex GBT’s Chief Legal Officer and Global Head of M&A, emphasized the importance of the CMA’s latest conclusions. “The updated provisional conclusions by the CMA is an important milestone toward the consummation of the transaction. The CMA’s revised findings reinforce the Company’s belief that the DOJ’s lawsuit is fundamentally flawed, taking a narrow and outdated view of competition, and disregarding the emergence of numerous significant competitors in business travel,” Bock stated.
Read more: Amex GBT Pushes Back Against DOJ Lawsuit Over CWT Acquisition
Amex GBT’s CEO, Paul Abbott, also highlighted the potential benefits of the acquisition. “If consummated, this transaction will accelerate investment and innovation in business travel, creating more choice and value for customers and suppliers, and more opportunities for CWT employees,” he said.
Despite the legal challenges in the U.S., the company remains committed to defending the transaction. Per Amex GBT’s statement, the company believes that the DOJ’s position does not accurately reflect the current competitive landscape of the business travel sector.
Source: Business Wire
Featured News
House Judiciary Committee Examines Antitrust Issues in Medical Residency Market
Mar 17, 2025 by
CPI
Belgian Competition Authority Accuses Roche of Anticompetitive Practices in Cancer Drug Market
Mar 17, 2025 by
CPI
PepsiCo to Acquire Prebiotic Soda Brand Poppi for $1.95 Billion
Mar 17, 2025 by
CPI
Tech Companies Face Tightened Online Safety Rules in the UK, Starting Monday
Mar 17, 2025 by
CPI
UK Government to Tighten Merger Scrutiny in New Plan by Chancellor Reeves
Mar 17, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Self-Preferencing
Feb 26, 2025 by
CPI
Platform Self-Preferencing: Focusing the Policy Debate
Feb 26, 2025 by
Michael Katz
Weaponized Opacity: Self-Preferencing in Digital Audience Measurement
Feb 26, 2025 by
Thomas Hoppner & Philipp Westerhoff
Self-Preferencing: An Economic Literature-Based Assessment Advocating a Case-By-Case Approach and Compliance Requirements
Feb 26, 2025 by
Patrice Bougette & Frederic Marty
Self-Preferencing in Adjacent Markets
Feb 26, 2025 by
Muxin Li